-
Development of a comprehensive blood biomarker system capable of assessing the background pathology of dementia using PET as a reference standard
Kenji TagaiResearcher, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology (QST) -
Multi-layer sequencing of germline, somatic, virus variants accelerate seeds development of autoimmune neurological diseases
Yukinori OkadaProfessor, The University of Tokyo Graduate School of Medicine -
Unleashing a New Era: Pioneering Therapies for α-Synucleinopathies
Nobutaka HattoriProfessor and Chairperson, Juntendo University Faculty of Medicine -
Discovery of brain circuit biomarkers and development of neurofeedback therapy based on generative/adversarial AI and digital brains
Aurelio CorteseHead, Brain Information Communication Research Laboratory Group, Advanced Telecommunications Research Institute International -
Dementia-treatment study based on cellular and molecular mechanisms of protective variants
Haruhisa InoueProfessor, Center for iPS Cell Research and Application (CiRA), Kyoto University